HDFC Mutual Fund has disclosed an aggregate holding of 5.017% in Alkem Laboratories Limited as of August 24, 2026. This disclosure, made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, follows an acquisition of 25,019 shares. The total paid-up equity share capital of Alkem Laboratories remains unchanged at Rs. 23,91,30,000.
HDFC Mutual Fund Increases Alkem Labs Holding
As per the requirements of Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, HDFC Mutual Fund has reported an increase in its aggregate holdings in Alkem Laboratories Limited. As of the close of business hours on August 24, 2026, the total holding by HDFC Mutual Fund schemes amounted to 5.017% of the company’s paid-up equity share capital.
Acquisition Details
The disclosed shareholding represents a paid-up equity share capital of Rs. 23,91,30,000, comprising 11,95,65,000 equity shares of Rs. 2/- each. The recent acquisition that triggered this disclosure involved 25,019 shares, which represents 0.021% of the total voting capital. The acquisition was made through the Open Market.
Compliance and Disclosure
The disclosure further states that the equity share capital and total voting capital of Alkem Laboratories remained unchanged before and after the said acquisition. The aggregate holding before the acquisition was 59,73,409 shares, representing 4.996% of the total voting capital. This notification is provided to the target company and relevant stock exchanges as required by regulations.
Source: BSE
